Showing results (131-140 of 172) with videos related to
Sort By:
Pageof 18
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypesM Bencherif, C M Eisenhour, R J Prince, et al.Neuropharmacology|September 15, 2014
Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellumPellegrino Lippiello, Eriola Hoxha, Floriana Volpicelli, et al.Journal of Neurochemistry|June 15, 2000
The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtypeR L Papke, J C Webster, P M Lippiello, et al.Current Pharmaceutical Biotechnology|December 8, 2010
Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophreniaAaron J Kucinski, Michal K Stachowiak, Scott R Wersinger, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 24, 2022
Maternal treatment with sodium butyrate reduces the development of autism-like traits in mice offspringClaudia Cristiano, Eriola Hoxha, Pellegrino Lippiello, et al.Frontiers in Aging Neuroscience|December 14, 2018
The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer's DiseaseEriola Hoxha, Pellegrino Lippiello, Fabio Zurlo, et al.Biochemical Pharmacology|August 23, 1996
Modulation of nicotine-evoked [3H]dopamine release from rat striatal synaptosomes by voltage-sensitive calcium channel ligandsR J Prince, K G Fernandes, J C Gregory, et al.Journal of Neurochemistry|December 1, 1994
Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomesM J Marks, S R Grady, J M Yang, et al.Physical Review Letters|April 26, 2018
Controlled Viscosity in Dense Granular MaterialsA Gnoli, L de Arcangelis, F Giacco, et al.Behavioural Pharmacology|December 9, 2014
The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonistsAaron Kucinski, Scott Wersinger, Ewa K Stachowiak, et al.Pageof 18